The Yes to Life Show – Nov 2022
Please visit the Yes To Life website to listen to the program. 50 years and counting Show #385 - Date: 11 Nov 2022 Ralph Moss has an interesting talk with The Yes To Life show host, Robin Daly....
Chemotherapy
Cancer, Incorporated: The Inside Story of the Corruption, Greed & Lies of Big Pharma
By Ralph W. Moss, PhD238 pages | Publication date: 2020 Cancer, Incorporated is a critical exploration of the pharmaceutical industry’s role in the development and marketing of cancer drugs....
Sympathetic Pediatric Oncologists
If you know of another pediatric oncologist who belongs on this list, please let us know. SYMPATHETIC PEDIATRIC ONCOLOGISTSContreras, Francisco, MDOasis of Hope, Playa de Tijuana, Mexico52 664...
Trophoblast From the Past
New Discoveries Breathe Life Into an Old Theory Discoveries by scientists worlds apart have unexpectedly breathed new life into an old view: the trophoblastic theory of cancer. The first...
What Keeps Me Working?
Hope!! I am writing this at five in the morning. For years, this has been the hour I get to my office and begin my work. I am armed with my computers, phone, files, and several walls of books,...
Tian Xian – Herbal Supplement
A Friendly Skeptic Looks at Tian Xian Many readers have asked my opinion of Tian Xian (pronounced dee-an-see-an), an herbal supplement and purported cancer cure that originated in China. There...
Are Coffee Enemas Good for Cancer?
E is for Enema When I first heard the words “coffee” and “enema” together, I almost fell off my chair laughing. At Memorial Sloan-Kettering Cancer Center, the big joke was, “With cream or sugar?”...
Photodynamic Therapy (PDT)
New Light on an Old ProblemPhotodynamic therapy (PDT) is much more effective for lung cancer than was previously thought, Thomas Jefferson University researchers said last week. The Philadelphia...
Graviola for Cancer?
Graviola–A Friendly Skeptic’s View An herbal treatment called Graviola burst onto the Internet in early 1999 and is now incorporated into many patients’ regimens. An increasing number of...
Manapol® and Ambrotose®
Hope or Hype?When a magazine ad or a disembodied voice on a TV commercial tells us that product X can eliminate wrinkles or help us lose weight while we sleep, we take these claims with a grain...
Galavit™ – Cancer Fighting Potential?
Galavit™ A Friendly Skeptics View I first came across Galavit® in November 2000, while on a tour of German complementary and alternative (CAM) cancer clinics. There had been an enthusiastic...
When is a Quack not a Quack?
Imposters Still Exist The eighteenth-century savant, Dr. Samuel Johnson, defined a quack as “a boastful pretender to arts which he does not understand, a vain boastful pretender…who proclaims his...
Am I a Soft-Core Quackbuster?
An Interesting Letter I received a very interesting email from a reader, who wrote: “It seems like you are skeptical of most alternative treatments due to the lack of publishing in scientific...
Does Goji Defeat Cancer?
More Than a Refreshing Beverage At the Cancer Control Society meeting in September I was assailed by sellers of a bottled drink made from goji berries. In my ignorance, I had never heard of this...
Cat’s Claw (Uncaria Tomentosa)
Treatment from the AmazonUña de Gato, or cat's claw, is the popular name for an herb scientifically called Uncaria tomentosa Willd. This is a woody vine, technically a member of the Rubiaceae...
Is There A Cancer Conspiracy?
Does a cure for cancer already exist? The American Cancer Society (ACS) recently conducted a telephone survey and found some disturbing trends. In particular, its pollsters discovered that 27...
Hydrazine Sulfate Trials and Tribulations
Where are your randomized controlled trials? … is the usual response to proponents of alternative cancer therapies. And, indeed, there are few rigorous clinical studies of most unconventional...
Cancer is Tough but you are Tougher – A conversation with Dr. Gary Onik
About Dr. Onik For over 40 years Dr. Gary Onik has been working on advances in cancer treatment. In addition to his medical practice, Dr. Onik is an Adjunct Professor of Mechanical...
About Ralph W. Moss, PhD
Ralph Moss is considered one of the foremost authorities in the world on complementary, integrative and alternative cancer treatments. Since 1974 he has written 12 books and three films about...
Why Precision Oncology Is Not The Solution
Personalized Medicine Precision oncology is defined as the “molecular profiling of tumors to identify targetable alterations.” Scientists have designed targeted drugs to attack mutations in...
Laetrile at Sloan-Kettering: Dr. Sugiura and Second Opinion
The Coverup of Laetrile (Amygdalin) at Sloan-Kettering Institute I began my job as a science writer at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City, in June 1974. My boss, T....
Is Laetrile Really Vitamin B17?
Crucial Facts "Laetrile's history has been complex, tortuous, kaleidoscopic. Beginning inauspiciously like hundreds of other small-time anticancer schemes, Laetrile soared to a notorious...
Down Goes Dr. Baselga
Sandpiper Trial On Saturday, June 2, 2018, Dr. José Baselga, MD, Physician-in-chief of Memorial Sloan-Kettering Cancer Center was enthused about the results of the SANDPIPER trial. He told the...
The Great Antioxidant Debate
Safety of Antioxidants In January 2013, James D. Watson, Ph.D., co-discoverer of DNA's double helix, published a paper in which he called into doubt the safety of antioxidants for cancer...
Keytruda: Toxic, Expensive and Not So Effective
Best Selling Cancer Drug in 2019 Keytruda® (pembrolizumab) is toxic, expensive, and not as effective as one would wish. But at $7.2 billion, it was the best-selling cancer drug in 2019. At the...
Imatinib (Gleevec) for Chronic Myeloid Leukemia
Glee Over GleevecAfter the announcement of herceptin, work accelerated on many other targeted agents for cancers. In that same year, clinical trials began for a new drug for chronic myeloid...
D-Mannose: A Sweet Option in the Treatment of Cancer
Warburg EffectA remarkable paper has been published in Nature. It has been known for a century that cancer cells are unusually dependent on the common sugar, glucose (the form that carbohydrates...
FDA Reverses Approval of Avastin
Stunning Reversal In a stunning rebuke to the former director of the Food and Drug Administration (FDA), an advisory panel has recommended removing the approval of the drug Avastin (bevacizumab)...
The Disturbing Case of José Baselga
Conflict of InterestThe best-publicized case of conflict of interest in cancer involved José Baselga, MD, Ph.D., the Physician-in-Chief, i.e., the top doctor of Memorial Sloan-Kettering Cancer...
Effectiveness of Bevacizumab (Avastin®)
A Study ShowedHow effective is bevacizumab (Avastin®)? A study of advanced colorectal cancer showed that progression-free survival went from 6.2 months with chemo to 9.2 months when Avastin was...
Shadows Fall on Anti-Angiogenic Drugs
The Main Hope of Conventional OncologyFor the past dozen years, drugs that inhibit the growth of new blood vessels—a strategy called anti-angiogenesis—have been the main hope of conventional...
FDA and FBI Raid Oklahoma Laetrile Clinic
The Camelot ClinicOn Tuesday, April 23, 2013, agents of the Food and Drug Administration (FDA), the Federal Bureau of Investigation (FBI), and the Oklahoma Medical Board raided an alternative...
What Are Phase IV Clinical Trials?
The Purpose Most people have heard of phase III clinical trials. But, according to Google Trends, only one-third as many are aware of the existence of the fourth phase of clinical trials. The...
What Are Surrogate Endpoints?
Progression Free SurvivalThe NCI Dictionary of Cancer Terms defines a surrogate endpoint in clinical trials as: “...an indicator or sign used in place of another to tell if a treatment works....
The Strange Case of Xalkori
A Great Success Story?Let us look at a drug that is considered one of the great success stories of the precision medicine approach, Xalkori (crizotinib). The story of Xalkori illustrates some of...
The Case of Xalkori (crizotinib)
Conflicts of InterestAlmost every study of a new cancer drug is riddled with conflicts of interest. Let us focus on one of these drugs, crizotinib (Xalkori®). But we could conduct the same sort...